Morse

Stephen M. Morse, DO, MPH & TM, FACOL, FASN

Associate Professor of Clinical Medicine
 

Clinical Location:

LSU Healthcare Network

Kenner Multi-Specialty Clinic
200 West Esplanade, Suite 701
Kenner, LA 70065
Phone: 504-412-1705
Fax: 504-412-1702

Request an Appointment

 

LSU Special Hypertension clinic
LSU Renal clinic

2000 Canal Street
New Orleans, LA 70112
Phone: 504-702-5700
Fax: 504-568-2127

 

Academic Location

Section of Nephrology
1542 Tulane Avenue
Room 330A
New Orleans, LA 70112
Phone: 504-568-2548
Fax: 504-568-2127

smorse@lsuhsc.edu

Degrees

DO - 1982
Oklahoma State University College of Osteopathic Medicine

MPH - 1994
Tulane University

Bio

Dr. Morse joined the faculty of LSU School of Medicine in 2000.after 17 years of clinical experience in Louisiana, Florida, Thailand, and Uzbekistan. Dr. Morse has been Medical Director of the Davita Hemodialysis Unit in Baton Rouge, LA since 2005 and was successful in opening the Crescent City Hemodialysis Unit and a peritoneal dialysis clinic in New Orleans in 2009. During this time, Dr. Morse also served three years as the Nephrology Fellowship Program Director

RESIDENCIES
Tropical Medicine 1983-1986
Tulane University , New Orleans, LA

Internal Medicine 1995-1997
Philadelphia College of Osteopathic Medicine, Philadelphia, PA

FELLOWSHIP
Nephrology 1997-1099
Albert Einstein Medical Center, Philadelphia, PA

CERTIFICATIONS
National Board of Examiners: Diplomate
American Society of Hypertension: Specialist in Clinical Hypertension
American Osteopathic Board of Internal Medicine: Internal Medicine
American Osteopathic Board of Internal Medicine : Nephrology
 

Research Interests Anemia
Hypertension
Nutrition
Teaching Activities

Lectures and clinical supervision for students, residents, and fellows

Board Review Course in Nephrology for the Family Practice Annual Board Review Course

Selected Publications

Kathresal A, Biundo J, Blais CM, Morse S, Reisin E. A rare case of Candida arthritis in a hemodialysis patient. Am J Med Sci. Nov; 336(5):437-40, 2008

Good D, Morse SA, Ventura HO, Reisin E. Obesity, hypertension and the heart. J. Cardiometab Syndr. 3(3): 168-72, 2008.

Thakur V, Morse S, Reisin E. Functional and Structural Renal Changes in the Early Stages of Obesity. Wolf G (ed): Obesity and the Kidney. Contrib Nephrol. Basel, Karger, Vol 151, pp 135-150, 2006.

Zhang R, Liao J, Morse S, Donelon S, Reisin E. The Kidney in the Metabolic Syndrome. Am J Med Sci. 330(6):319-325, 2005.

Morse SA, Zhang R, Thakur V, Reisin E. Hypertension in the Metabolic Syndrome. Am J Med Sci. 330(6): 202-110, 2005.

Morse SA, Bravo PE, Morse MC, Reisin E. The Heart in Obesity Hypertension. Expert Rev Cardiovasc Ther. Jul; 3(4): 647-658, 2005.
 

Additional Info

CURRICULUM VITAE

 

Stephen Anthony Morse, D.O., MPH & TM, FACOI, FASN

 

 

Education:

 

  1. Indiana University

Bachelor of Arts (Linguistics)

(Minors in Biology & Chemistry)

Bloomington, Indiana

 

  1. Oklahoma State University

Doctor of Osteopathic Medicine & Surgery

Oklahoma State University-College of Osteopathic Medicine

Tulsa, Oklahoma

 

      1994                Tulane University

Master of Public Health & Tropical Medicine

New Orleans, Louisiana

 

POST GRADUATE TRAINING:

 

  1. Des Moines General Hospital

(Rotating Internship)

Des Moines, Iowa

 

1983-1986                   Tulane University School of Public Health

                                    Residency in Public Health & Preventive Medicine,

(specializing in Tropical Medicine)

New Orleans, Louisiana

 

1984-1986                   Mahidol University

Faculty of Tropical Medicine/Hospital for Tropical Diseases

Tropical Medicine (including field work in Korat, Mekong River Valley – northeast Thailand, Chiangmai, Chiangrai & Maehongson Provinces.

Bangkok, Thailand

 

  1. Philadelphia College of Osteopathic Medicine

Resident, Internal Medicine

Philadelphia, PA

 

  1. Albert Einstein Medical Center

Fellow in Nephrology

Kraftsow Division of Nephrology

Albert Einstein Medical Center

Philadelphia, PA

 

TEACHING & MEDICAL EXPERIENCE:

 

  1. Thibodaux General Hospital

(Emergency Room Physician)

Part-time

Thibodaux, Louisiana         

 

1986                            Kwai River Christian Hospital

                                    (Locum Tenens)

                                    Sangklaburi, Thailand

 

  1. Tribal Children’s Hostel

(Director)

Chiangmai, Thailand

 

  1. Emergency Care Physician, Inc

(Staff Physician)

Indianapolis, IN

 

 

  1.                            Central Asia Free Exchange

(Medical Consultant)

Uzbekistan

 

  1.                             Crosslink International

(Medical Consultant)

Uzbekistan

 

1994                            Crosslink International

                                    (Medical Consultant in Research)

                                    Working on anemia & nutrition research in the Muynak district

                                    of Karakalpakistan Uzbekistan

 

  1. Kachinland Foundation

(Director of Relief & Medical Aid)

Projects along Sino-Kachin border & Thai-Burma border,  involving relief aid, MCH programs, handicap rehabilitation, income-generation, etc.

 

  1. North Burma Christian Mission (Thailand)

(Director of Medical Services)

North Burma (Thailand)

Chiangmai, Thailand

 

  1. Primus Clinic

(Staff Physician)

Tampa, Florida

 

1999-2000                   Terrebonne General Medical Center

(Staff Physician)

Houma, Louisiana

 

1999-2000                   St. Anne General Hospital

                                    (Staff Physician)

Raceland, Louisiana

 

1999-2000                   Thibodaux Regional Medical Center

(Staff Physician)

Thibodaux, Louisiana

 

1999-2000                   Leonard J. Chabert Medical Center

(Staff Physician)

Houma, Louisiana

 

1999-2000                   Ochsner Foundation/Clinic

Department of Medicine (Staff Nephrologist)

in the Bayou Region of Louisiana and in New Orleans, Louisiana

Medical Director of 2 Dialysis Units in Thibodaux & Houma, Louisiana. 

 

2000-2006                   Louisiana State University Health Sciences Center

                                    Department of Medicine/ Section of Nephrology

                                    Assistant Professor of Clinical Medicine

                                    New Orleans, Louisiana

 

2006-Present               Louisiana State University Health Sciences Center

                                    Department of Medicine/ Section of Nephrology

                                    Associate Professor of Clinical Medicine

                                    New Orleans, Louisiana

 

June 15 2006               Louisiana State University Health Sciences Center

                                    Department of Medicine/ Section of Nephrology

                                    Program Director, Nephrology Fellowship

                                    Associate Professor of Clinical Medicine

                                    New Orleans, Louisiana

 

Dec 2005-Present        Davita Baton Rouge Hemodialysis Unit, LA

                                    Medical Director

 

Sept 2007-Present       Hypertension Lead for System Wide Disease Management

                                    Louisiana State University Healthcare Services Division

 

CERTIFICATIONS:

 

1983                            Diplomate, National Board of Examiners

                                    7/1/83, #9344

 

  1. American Osteopathic Board of Internal Medicine

Internal Medicine Certification

8/26/98, #1915

 

  1. American Osteopathic Board of Internal Medicine

Nephrology Certification

8/23/99, #1915

 

                                    DEA License, BM6426286 (exp 01/31/08)

                                    Louisiana DEA, 27169 (exp 08/01/07)

                                    NPI Number, 1396767034

                                    Upin # E66805

                                    Medicaid Provider # 1557978

                                    Medicare Provider # 5E814

                                    LSU # 355049

 

2003                            Specialist in Clinical Hypertension

                                    American Society of Hypertension

                                   

LICENSURES:

 

  1. Osteopathic Physician & Surgeon/(FLEX) #02012 (lapsed)

Iowa

 

1983                            Medicine & Surgery (Reciprocity) L#06198R

Louisiana

 

1983                            Doctor of Osteopathy (National Boards) #2332

                                    Oklahoma

 

1989                            Osteopathic Physician (Reciprocity) #020001145

                                     Indiana

 

1994                            Osteopathic Physician (Reciprocity)/(allowed to lapsed)                                                       #OS-0006827

                                     Florida

 

1995                            Osteopathic Physician (Reciprocity) #DOS-763 (lapsed)

                                    Hawaii

 

1997                            Osteopathic Physician (Reciprocity) #OS-009766-L; (lapsed)

                                    #OT-004916-T

                                    Pennsylvania

 

HONORS:

 

  1. Dean’s List

Milligan College

 

  1. Dean’s List

Indiana University

 

  1. Platinum Award (for FMC-Central, New Orleans HDU)
Fresenius Medical Care, North America

    

 

  1. Silver Award (for FMC-Central, New Orleans HDU

Fresenius Medical Care, North America

 

Fellow American College of Osteopathic Internists (FACOI)

 

2006                            Fellow American Society of Nephrology (FASN)

 

Academic, Professional, and Research Appointments:

 

            2000 -Assistant Professor of Clinical Medicine, LSU                                       Health Sciences Center

 

            2006 – Associate Professor of Clinical Medicine, Lsu                                    Health Sciences Center

 

            2006 – Program Director, Nephrlogy Fellowship                                            program, Lsu Health Sciences Center

 

 

 

SOCIETY AFFILIATIONS: Past and Current

 

American Osteopathic Association (041942)

American Medical Association

American College of Osteopathic Internists (0915)

American College of Physicians (01079858)

Louisiana State Medical Society

American Society of Nephrology (00112402)

National Kidney Foundation

Renal Physician's Association

International Society of Nephrology

American Society of Hypertension

 

TEACHING EXPERIENCE/RESPONSIBILITIES:

 

            Village Health Worker Training

 

            Advance Health Worker/Medic Training

 

            Lectures to Medical Students

 

            Lectures to Residents

 

            Lectures to Fellows

 

            Family Practice Annual Board Review Course (Nephrology)

 

THESIS AND DISSERTATION COMITTEES:

           

2001    Denise Neu

            Ph.D. Dissertation

            University of New Orleans, New Orleans, LA

(Her dissertation focused on the placement of hemodialysis units in the greater New Orleans area.)

 

Teaching Experience/Responsibilities:

 

  • Daily teaching rounds with the fellows, residents, interns, and students on the renal service at University Hospital and at the Medical Center of Louisiana in New Orleans (MCLNO).  Teaching is conducted on a case by case basis and covers all relevant aspects of a particular case.  In addition, daily topics are chosen and reviewed with the team during the course of the month to include a representative introduction to the field of kidney disease, electrolyte disorders, acid base abnormalities, drug dosing and pharmacokinetics and issues relating to hypertension.  This involves approximately four to five months out of the year.  In addition, a similar but less vigorous regimen of teaching is pursued during the monthly call weekends.

 

  • Residents, interns and students were taught on a daily basis during rounds, round table discussions and lectures during the annual month-long Firm Service from 2001-2003.

 

  • As the Section’s specialist in dialysis, all the fellows rotate through the dialysis unit where they are exposed to and taught both basic and advanced principles of dialysis and care of the End Stage Renal Disease patient.  Once a month, chemistries are reviewed with the patient care team (nurses, dietician, social worker, manager, education nurse) and the fellows are invited to attend, coached and encouraged to participate in the process.  In addition, urea kinetics is discussed on each patient and appropriate management objectives and plans are made.

 

  • Fellows, residents, interns and students on the Renal Consult Service attend a biweekly renal conference with the Renal Staff in the Section office area where different topics and difficult cases are presented and discussed in a round table fashion.  These meetings are often the center for lively debates between staff and house staff and relevant approaches, diagnostic workups, treatment plans and management plans are discussed and taught. 

 

  • Some topics that I have covered at these meetings include, nutrition in ARF patients, nutritional issues in CKD and ESRD patients, urea kinetics, principles and practice of dialysis, nephrolithiasis, neurological issues in kidney disease, proteinuria/nephritic syndrome and diabetic nephropathy.

 

  • Fellows, residents, interns and students are taught on a case by case and individual basis in the Renal Clinic, where urine analysis is performed and urine is examined under a light microscope.  Blood and urine tests from the hospital lab are reviewed with the house-staff and a differential diagnosis is made on the basis of the clinical exam, patient history and the diagnostic tests.

 

  • When patients with suspected glomerular disease are found in clinic or during hospital rounds, I am responsible for making arrangements for and obtaining a renal biopsy.  The fellow and other interested house-staff are then taken through the proper steps of conducting a renal biopsy.  After an initial demonstration, the fellow is encouraged to perform the procedure under my supervision.  Biopsy specimens are often reviewed with the Pathologist either in his office or occasional during a case presentation in our weekly meetings.

 

  • I have supervised the fellows and residents in placing Quinton dialysis catheters and central line catheters, teaching them safe, sterile and proper techniques for the placement of dialysis and central line catheters. 

 

  • I have presented a 3 hour long board review course in nephrology for a Family Practice Annual Board Review Course.  The course reviewed aspects of renal anatomy, physiology, pathophysiology, renal related diseases and their care and management. I have been invited to repeat the lecture again this year.

 

  • I have supervised the fellows and residents in the research, writing, and presentation of abstracts and posters for the annual LSU Research Day poster presentations, at the Southern Society of Medicine meetings and the American Society of Nephrology.

 

  • I have been a volunteer judge for LSU Research Day poster presentations for the past three years (2003-2005).

 

Curriculum Development/Implementation

 

I am responsible for curriculum development regarding chronic kidney disease, ESRD, and nutrition.  I have reviewed many articles and books, attended many seminars and conferences to continuously stay abreast of the field.

 

Since July of 2006 I have been responsible as the Program Director of the Nephrology Fellowship for curriculum development.  I am in touch with all the fellows on a weekly basis and intimately involved in planning and implementing the curriculum.  I have rewritten the overall curriculum for the fellowship.  I am responsible for keeping in touch with the other faculty and Assistant Program Director.

 

Creation of Enduring Teaching Materials

 

Power Point lectures on:

 

            Nutrition in Renal Disease

            Chronic Kidney Disease

            End Stage Renal Disease

            Acute Renal Failure

            Renal Tubular Acidosis

            Renal Osteodystrophy

            Potassium Abnormalities

            Nephrolithiasis

            Calcium and Phosphorus Abnormalities

            Metabolic Acidosis

            Metabolic Alkalosis

            Out-patient Assessment of Kidney Disease

            Nutritional Factors in Hypertension

            Nutrition in Peritoneal Dialysis

            Nutrition and Metabolism in Acute Renal Failure

            Neurological Issues in ESRD

            Hemodialysis Principles and Practice

            Diabetic Nephropathy

            Dysnatremia

            Peritoneal Dialysis

 

Departmental/Interdisciplinary Conferences – Morning Report, Grand Rounds, Tumor Board, Departmental Seminar Series, etc

 

  1. Grand Rounds, “Nutrition in Renal Disease”

 

  1. Grand Rounds: “Management of Chronic Kidney Disease: Strategies for a New Paradigm”

 

      2004      Nutritional Factors in Hypertension” (LSU-Nutrition Week Lecture)

 

2005     Grand Rounds: “Uremia”

 

2007      Grand Rounds: Nephrotic Syndrome

 

Special Clinical Rounds – Chairman’s Rounds, Chief’s Conference, etc

 

Occasional Panelist on Medicine Department Tuesday Case Presentation, Noon Conference

 

Graduate Students Trained:

 

I have participated in the training of LSU medical students, interns and residents as well as mentoring visiting foreign medical graduates rotating through our section since 11/2000 to the present.

 

Thesis and Dissertation Committees:

 

2001    Denise Neu

            Ph.D. Dissertation

            University of New Orleans, New Orleans, LA

            (Her dissertation focused on the placement of hemodialysis units in the     

            greater New Orleans area.)

 

Post-Doctoral or Post-Residency Fellows Trained:

 

  1.      Kenneth Kellum, M.D.          

            Avanelle Jack, M.D.

            Dwayne Bergeaux, M.D.

2000-2002       Gregory Maidoh, M.D.

            An Dang, M.D.

            Christopher Westervelt, M.D.

2001-2003       Andy Blalock, M.D.

            Judy Crump, M.D.

2001-2002       Betcy Thomachan, M.D.

2002-2004       William Gabbard, M.D.

            Shaminder Gupta, M.D.

            Malika Morse, M.D.

            Kenneth Tourgeman, M.D.

2003-2005       Shawn Donelon, M.D.

            Kathryn Elmore, M.D.

2004-2006       Melisa Harrington, M.D.

            John Higgenbotham, M.D.

            Dana Walters, M.D.

            Kimberly Williams, M.D.

2005-2007       Arshad Asghar, M.D.

               Michelle Larroque, M.D.

2006-2008       Amer Kathresal, M.D.

                        Ben Lee, M.D.

                        Michael Liu, M.D.

                        Carlos Mendez, M.D.

2007-2009       Qin Ren, M.D.

                        Zohreh Soltani, M.D.

2008-2010       Jay Patel, M.D.

                        Ryan McDonald, M.D.

                        Michael Bouyarden, M.D.

                        Arleta Kitlas, M.D.

 

 

Grants and Contracts: (note role on grant; i.e. PI, co PI, consultant, etc)

National Foundations: Funded

Co-Investigator

 

LOUISIANA BOARD OF REGENTS (lIEF)            2000-2005        $739,310

Occupational Medicine Research Center: lob Stress Related Hypertension.

Role: Co-Investigator of the Occupational Medicine Research Center.

 

NIH ALLHAT                                                            1998-2003        $100,000

Antihypertensive and lipid lowering treatment to prevent heart attack trial.

 

National Kidney Foundation-Louisiana.  2006-2007                         $10,000

End Stage Renal Disease in Subjects Enrolled in the Bogalusa Heart Study: A long term community study of a rural biracial (White/Black) population.

PI: Stephen Morse, Co-investigators: Efrain Reisin, Gerald Berenson

 

Grants: Funded: Co-Investigator

 

 

AMGEN PROTOCOL 125 -             2002-2004                   $125,540                      

A randomized double-blind study comparing Aranesp and rHuEPO in the treatment of anemia in African- American subjects with chronic renal failure receiving hemodialysis. 

 

AMGEN Protocol 20000188              2002-2003                    $46,912.50               

A Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) in Secondary Hyperparathyroidism of Chronic Kidney Disease (Hemodialysis and Peritoneal Dialysis).

 

BOEHRINGER INGELHEIM PHARMACEUTICALS INC.           2004      $89,000

A prospective, randomised, double-blind, double-dummy, forced-titration, multicentre, parallel group, one year treatment trial to compare MICARDISÒ (telmisartan) 80 mg versus COZAARÒ (losartan) 100 mg, in hypertensive type 2 diabetic patients with overt nephropathy (AMADEO Study)

                                          

ABBOTT LABORATORIES            2004                            $68,100                       

A Phase IV, prospective, randomized, active-controlled, double-blind, double-dummy, multi-center study to evaluate the survival benefits of Zemplar relative to Calcijex in subjects with stage V Chronic kidney disease on hemodialysis                

 

PREMIER RESEARCH                    2002-2003                               $30,018

A prospective randomized double-blind parallel group multicenter titration study comparing the safety and efficacy of Diltiazem hydrochloride's extended release tablets taken at bedtime, to amlodipine taken in the morning in achieving optimal blood pressure control in African-American patients with Stage I and essential hypertension.

 

ASTRAZENECA (PAREXEL) TRIAL NUMBER: 4522IL/0065 

                                                             2001-2003                              $30,600

A 6-week, Dose-comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin, Cerivastatin, Pravastatin, and Simvastatin in Subjects with Hypercholesterolemia.

 

BAYER                                              1999-2001                               $199,760

A randomized, double-blind, parallel group evaluation of usual care plus Cerivastatin 0.4 mg once daily compared with usual care (placebo) alone in patients with End Stage Renal Disease (ESRD) New to Hemodialysis: Cerivastatin Heart Outcomes in Renal Disease: Understanding Survival (CHORUS) 

 

ASTRAZENECA (AMAZE) LP PROTOCOL NO.: 304  2001-2002             $11,000

Antihypertensive Efficacy of Adding Candesartan Cilexetil to Lisinopril in Comparison to Up-titration of Lisinopril: A Multi Center Trial Using ATACAND®-ZESTRIL® versus ZESTRIL® to Evaluate the Effects of Lowering Blood Pressure.

                                               

AMGEN Protocol Number: NESP 990788                      2001-2002             $ 15,500

"A study evaluating the initiation and titration of fixed doses of novel   Erythropoiesis Stimulating Protein (NESP) Therapy in subjects with chronic renal insufficiency (CRI)."

 

ASTRAZENECA PHARMACEUTICALS LP. 4522US/0002 2001-2003   $38,400

A 6-week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolemia in African American Subjects

 

ORTHO-BIOTECH PROTOCOL # PR03-32-025                2004-2005

A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients with Idiopathic Anemia of Aging (IAA) Receiving PROCRIT® (Epoetin alfa).

 

ORTHO-BIOTECH  PROTOCOL # PR03-32-026               2004-2005

A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function inElderly Patients with Anemia of Chronic Disease (ACD) Receiving PROCRIT® (Epoetin alfa).

 

Pending funding :

 

Effects of a Novel Peroxisome Proliferators-Activated Receptors of Alpha and Gamma Subtypes Agonist Tesaglitazar on Type 2 Diabetic Nephropathy in Obese Zucker Rats. Field initiated study application, AstraZeneca. $160,000

 

Effects of HMG-CoA Reductase Inhibition on Obese Zucker Rats. Field initiated study application, AstraZeneca. $ 180,000

 

Collaborative Study (RUSH UNIV)

Tranilast Therapy in Type 1 Diabetic Nephropathy.

 

KERYX PHRMACEUTICALS, PROTOCOL NO.: KRX 03-013a.

An Exploratory, Randomized, Double-Blind, Multiple Dose Study of KRX-101 (Sulodexide Gelcaps) for the Treatment of Type 1 and Type 2 Diabetic Nephropathic Patients with Persistent Microalbuminuria.

 

SHIRE

A Phase IIIb, Multi-Center, Two-Cohort, Randomized Study, with an Open-Label Run-In and a Long-Term Extension Phase, Assessing an Extended Dose Range of Lanthanum Carbonate in End Stage Renal Disease Subjects Receiving Hemodialysis.

 

HOFFMANN-LAROCHE INC. Protocol Number: BA16736B with PK

An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using intravenous injections of RO0503821 in patients with chronic kidney disease who are on dialysis.

 

AstraZeneca

A 24-week, randomized, Parallel-Group, Multi-Centre, active-Controlled (pioglitzone) Study of Renal Effects of Tesglitazar in Patients with Type 2 Diabetes Mellitus (ARMOR)

 

Non-funded applications (last three years): Principal Investigator

 

 

2004-2005       Hoffman-LaRoche Inc.  An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using intravenous injections of RO0503821 in patients with chronic kidney disease who are on dialysis.

 

2004-2005       Hoffman-LaRoche Inc.  A randomized, controlled, open-label, multi-center, parallel-group study to demonstrate the efficacy and safety of RO0503821 when administered with pre-filled syringes for the maintenance treatment of anemia in patients with chronic kidney disease who are on dialysis.

 

Research Review Committee: (NIH study section, etc)

 

Reviewer of Guidelines (2001) for:

National Kidney Foundation: Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification (A report from the Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative)

 

Inventions and Patents: None

 

MAJOR REPORTS AND PAPERS:

 

  1. Morse S. Immunologic Aspects in Leprosy Vaccine Development.  Paper prepared for Clinical Tropical Medicine, Tulane University, New Orleans, Louisiana, 1983.

 

  1. Morse S, Morse L.  Health Status in Three Opium Growing Lisu Villages.   Mahidol University, Thailand, 1985.

 

  1. Morse S, Morse L, and Adulya Viriyavejakul. Osteopathic Medicine in the USA, 1985.  Submitted to the Royal Thai Medical Society

 

  1. Morse S. Civil War and Opium Eradication: American Involvement in Burma. Journal of the National Democratic Front of Burma, pp 185-187, 1987.

 

  1. Morse S. Burma:  A Briefing Book.  Kachinland Foundation.  Last version compiled1992.

 

  1. Morse S. The development of Kachin Nationalism and the Union of Burma.  Honors Paper/Monograph in Political Science, IUPUI, April, 1992.

 

  1. Morse S. Internal Report:  Preliminary Health Survey Trip to the Union of Burma and the Northernmost District of Putao, Project MEND, Internal Report Monographs I-IV, 1994.

 

  1. Stephen Morse, Eric Bloom, Rasib M Raja.  Determinants of Nutrition and the Subjective Global Assessment in Peritoneal Dialysis Patients.  Primary Research Study at the Kraftsow Division of Nephrology, Albert Einstein Medical Center, Philadelphia, PA, August, 1999.  Unpublished manuscript.

 

PUBLICATIONS (In Peer Reviewed Journals)

 

  1. Morse S. A Short Update on Rawang Phonology.  Linguistics of the Tibeto-Burman Area, Volume 11:2, pp. 120-132, 1988.

 

  1. Morse S. Five Rawang Dialects Compared Plus More.  David Bradley, Eugenie, JA; Henderson & Martine Mazaudon eds, Prosodic Analysis and Asian Linguistics: to honor R.K. Sprigg. Pacific Linguistics, C-104, pp 237-250, 1988.

 

  1. Kung, SC, Aravind B, Morse SA, Jacobs LE, Raja R. Tunneled Catheter-Associated Atrial Thrombi: Successful Treatment with Chronic Anticoagulation. Hemodialysis International. 5:32-36, 2001.

 

  1. Kung SC, Morse SA, Bloom E, Raja RM. Acid-Base Balance and Nutrition in Peritoneal Dialysis. Advances in Peritoneal Dialysis,17: 235-237, 2001.

 

  1. Thakur V, Zhang R, Morse S, Reisin E. Obesity Hypertension: The Effects on Cardiovascular and Renal Systems. Cardiovascular Reviews and Reports. 23:213-219, 2002.

 

  1. Zhang R, Thakur V, Morse S, Reisin E. Renal and Cardiovascular Considerations for the Nonpharmacological and Pharmacological Therapies of Obesity-Hypertension. J Hum Hypertens 16(12): 819-827, 2002.

 

  1. Morse SA, Dang A, Thakur V, Zhang R, Reisin E. Hypertension in Chronic Dialysis Patients: pathophysiology, monitoring, and treatment.  Am J Med Sci. Apr; 325(4):194-201, 2003.

 

  1. Morse SA, Bravo PE, Morse MC, Reisin E. The Heart in Obesity Hypertension. Expert Rev Cardiovasc Ther. Jul; 3(4): 647-658, 2005.

 

  1. Morse SA, Zhang R, Thakur V, Reisin E. Hypertension in the Metabolic Syndrome.  Am J Med Sci.  330(6): 202-110, 2005.

 

  1. Zhang R, Liao J, Morse S, Donelon S, Reisin E. The Kidney in the Metabolic Syndrome.  Am J Med Sci. 330(6):319-325, 2005.

 

  1. Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and Hypertension in Obesity. Submitted to Journal of Vascular Health and Risk Management, February 2006.

 

  1. Good D, Morse SA, Ventura HO, Reisin E.  Obesity, hypertension and the heart.  J. Cardiometab Syndr. 3(3): 168-72, 2008.

 

  1. Kathresal A, Biundo J, Blais CM, Morse S, Reisin E.  A rare case of Candida arthritis in a hemodialysis patient.  Am J Med Sci. Nov; 336(5):437-40, 2008

 

BOOKS AND CHAPTERS:

 

  1. Thakur V, Morse S, Reisin E.  Functional and Structural Renal Changes in the Early Stages of Obesity.  Wolf G (ed): Obesity and the Kidney.  Contrib Nephrol.   Basel, Karger, Vol 151, pp 135-150, 2006.

 

  1. Morse S. An Appreciation (Introduction). In: Shelby Tucker. Among Insurgents-Walking Through Burma.  London: Radcliffe Press, 2000.

 

PUBLISHED INTERVIEWS

 

  1. Hypertension, obesity and the metabolic syndrome.  Expert commentary by Stephen Morse, @ univadis.co.uk, 10/29/06.

 

  1. Hypertension and Pre-hypertension.  Expert commentary by Stephen Morse with David Winkler-Schmit on “Health Talk”, Gambit Weekly, 29 (19): 45, May 6, 2008.

 

ASTRACTS AND POSTERS

 

1.   Stephen Morse, Eric Bloom, Rasib M Raja.  Determinants of Nutrition and the     Subjective Global Assessment in Peritoneal Dialysis Patients.  Poster presented at             the Twentieth Annual Conference of Peritoneal Dialysis.  San Francisco, CA,         February 2000

 

  1. Morse M, Morse S, Aguilar E, Liao J, Gabbard W, Richards R, Butterbaugh G, Roques B, Costa R, Reisin E. Carotid Ultrasonography (US) and Mental Stress-induced hemodynamic and Neurohormonal Responses: Potential Markers of Metabolic Syndrome.   Poster, LSUHSC, Research Day, New Orleans, LA, January 2004. Presented to the Southern Medical Association, New Orleans, LA, February 2004.

 

  1. Zhang R, Butterbaugh G, Aguilar EA, Liao J, Morse S, M Rose, Roques B, Thomson J, Zhang, Reisin E.  Pre-hypertension is associated with metabolic risk factors and early cardiovascular disease in clinically healthy young professionals.  Departments of Medicine & Psychiatry, Biostatistics Program, Research Day February 18, 2005. Louisiana State University Health Sciences Center, New Orleans, Louisiana.

 

  1. Morse S, Butterbaugh G, Aguilar EA, Liao J, Bravo-Valenzuela PE, Rose M, Roques B, Thomson J, Zhang R, Reisin E. Ambulatory blood pressure is superior to office blood pressure in predicting early vascular disease in non-hypertensive healthy you professionals. Presented as poster at American Society of Hypertension, 20th Annual Scientific Meeting and Exposition, San Francisco, May 2005.

 

  1. Ashgar A, Reisin E, Morse S.  Lessons from Hurricane Katrina: A Teaching Hospital Perspective.  Submitted for Southern Medical Association Annual Meeting, Atlanta, GA, February 2006.

 

  1. Philip Ebnezer, PhD1, Jie Liao, MD, PhD2, Masudul Haque, PhD1, Nithya Mariappan, PhD1, Joseph Francis, DVM, PhD1, Erwin Aguilar, PharmD, MSc, MPH2, Stephen Morse, DO, MSPH&TM2* and Efrain Reisin, MD2*. Rosuvastatin, an HMG-CoA Reductase Inhibitor, Improves Metabolic Abnormalities and attenuates microalbuminuria in Obese Zucker Rats. 1Comparative Biomedical Sciences, LSU School of Veterinary Medicine, Baton Rouge, Louisiana, United States, 70803 and 2Internal Medicine, Section of Nephrology, LSU Health Sciences Center, New Orleans, Louisiana, United States, 70112. Submitted to American Society of Hypertension 22nd Annual Scientific Meeting and Exposition May 19-22, 2007 Chicago, Illinois. 

 

  1. Morse S, Ashgar A, Muntner P, ,Aguilar E,Patel D, Reisin E, Berenson G.  Determinants of End Stage Renal Disease in the Bogalusa Heart Study Population. Filename: 555325 ASN Renal Week 2007.

 

  1. Efrain Reisin, MD*1, B S Lee, MD1, M L Larroque, MD1, J Liao, MD, PhD1, P Ebenezer, PhD3, M Haque, PhD3, N Mariappan, PhD3, E A. Aguilar, PharmD, MSc, MPH1, S A Morse, DO, MPH1, L X Hu, PhD2 and J Francis, DVD, PhD3. 1Nephrology & Hypertension, LSU Health Sciences Center, New Orleans, LA, United States; 2Pathology, Tulane University, New Orleans, LA, United States and 3Comparative Biomedical Sciences, LSU School of Veterinary Medicine, Baton Rouge, LA, United States.  Effect of the HMG-CoA reductase inhibitor rosuvastatin on early kidney nephropathy in obese Zucker rats. Filename: 555872 ASN Renal Week 2007

 

  1. Tina Moll, Lucia Sicinschi, Stephen Morse.  Proteinuria the tip of the iceberg: A critical finding in HIV associated nephropathy.  Poster at Medicine Day, LSUHSC, New Orleans, January 2009.

 

  1. Zohreh Soltani MD, Michael Bouyadren MD, Avanelle Jack-Jackson MD, Stephen Morse D.O., and Efrain Reisin MD.  Renal failure due to leukemic infiltration in chronic lymphocytic leukemia: A case report. Submitted for Southern Medical Association Annual Meeting, New Orleans, LA, February 2009

 

 

CONTINUING MEDICAL EDUCATION (CME):

 

Attended:

 

2000: Thibodaux Regional Medical Center Grand Rounds/CME – 17 hours; 20th Annual Conference on Dialysis – 15 hours; University of Maryland School of Medicine, COACH Office Practice Seminar, 3 hours

 

2001: LSU Grand Rounds/CME – 23 hours; Annual Conference on Dialysis – 18.5 hours;

 

2002: LSU Grand Rounds/CME – 28 hours; American College of Osteopathic Internists 62nd Annual Convention – 39 hours; Tulane University, Cardio-Renal Seminar – 4 hours;

 

2003: 108th Annual Convention and Scientific Seminar/AOA – 19 hours; Dynamic Poster Session – 2 hours; American Society of Hypertension – 28 hours; Prevention of Kidney Disease in Minority Groups and Emerging Nations – 13.9 hours; Board Review/American Society of Nephrology – 61 hours; 63rd Annual Convention and Scientific Session/ ACOI – 44.5 hours; Annual Meeting and Scientific Expo/ASN – 3 hours; LSU Medicine Grand Rounds – 21 hours; The ASN 36th Annual Meeting and Scientific Exposition – 30 hours

 

2004: 11th Annual National Scientific Sessions/The Consortium for Southeastern Hypertension Control – 18 hours; PACE Workshop – 2 hours; LSU Medicine Grand Rounds – 25 hours; American Society of Hypertension – 12 hours; American College of Physicians – 28 hours

 

2005: American Society of Hypertension – 13 hours; Advances in ESRD 2005: 7th International Conference on Dialysis – 18 hours; American Society of Hypertension – Annual Scientific Meeting and Exposition – 44 hours; American Society of Nephrology – 34 hours; LSUHSC School of Medicine in New Orleans – 20 hours

 

2006: ACOI 66th Annual Convention and Scientific Sessions – 42.5 hours; 66th Annual Convention and Scientific Sessions of ACOI - AIDS Education -2 hours; Johns Hopkins University School of Medicine – 1 hour; University of Texas SW Medical School CME – 2; ASN on line CME – 18.5 hours; UF College of Medicine – 1 hour; AAIM/APDIM Oct 26, NO – 8 hours; American Academy of CME, Inc – 1 hour; NEJM CME – 1 hour; Medscape CME – 3.25 hours; ASN Internet CME Program, Workshop Cases – Non-Anion Gap Acidosis 1.5 hours; ASN Internet CME Program, Membranoproliferative GN Pathology Update1.5 hours; ASN Internet CME Program, Post-Transplant Infections1.5 hours; ASN Internet CME Program, Role of Glycemic Control, Obesity in Peritoneal Dialysis Patients1.5 hours; ASN Internet CME Program, Current Concepts in Neurohormones: Vasopressin and the Kidney 1.5 hours; ASN Internet CME Program, Preservation of Residual Renal Function in HD patients2 hours; ASN Internet CME Program, Transplantation: Key Issues2 hours; ASN Internet CME Program, The Role of Iron Deficiency Anemia Management2 hours; ASN Internet CME Program, Mineral Metabolism and Mortality in CKD2 hours; ASN Internet CME Program, Resistant Hypertension – Reducing CV Events  – 2 hours;

 

2007:  American Society of Hypertension – 13 hours; American Society of Nephrology, Renal Week -32.5 hours; ASN: Glomerulonephritis symposium – 12.5 hours; ASN on line NephSAP V6#2, Renal Bone Disease6 hours; NEJM CME Online – 5 hours;

 

2008:  Southern Society of Clinical Investigators -  hours; University of Kentucky – online 2.5 hours; NEJM CME Online – 1 hour;  LSUHSC Department of Medicine Grand Rounds – 13 hours; ASN on line NephSAP V7#3, Glomerular, Vascular, and Tubulointerstitial Disease6 hours; ASN on line NephSAP V7#5, Renal Bone Disease, Disorders of Divalent Ions and Nephrolithiasis 6 hours; ASN on line NephSAP V7#1,  Transplantation6 hours; ASN on line NephSAP V7#6, End-Stage Renal Disease and Dialysis 6 hours; ASN on line NephSAP V7#2, Hypertension6 hours; ASN on line NephSAP V8#1, Pediatric Nephrology6 hours; ASN on line NephSAP V7#4, Renal Imaging 6 hours; ACOI 68th Annual Convention and Scientific Sessions – 42.5 hours;

 

2009: Saint Thomas Health Services “Da Vita 2009 Annual Physician Leadership Meeting” – 11.75 hour

 

 

PRESENTATIONS/SPEAKING:

 

Nephrology Review – Annual Family Practice Board Review Course, New Orleans, since 2004.

 

Humanism During Hurricane Katrina at Charity Hospital – 9th Annual Forum on Health Care Effectiveness.  Baton Rouge, February 21, 2006

 

The Katrina Experience at Charity Hospital – Annual Meeting of the Southern Society of Clinical Investigators.  Atlanta, March 5, 2006

 

           

COMMUNITY SERVICE/ACTIVITIES:

 

            Kachinland Foundation: Secretary/Treasurer

 

            Project MEND: Chairman

 

            Tribal Children’s Hostel (Thailand): Consultant

 

            Pan-Kachin Development Society: Board of Directors

 

 

 

CURRENT CLINICAL SERVICE:

 

            CLINICS:     

                        MCLNO Renal Clinic: Staff

                        MCLNO Hypertension Clinic:  Staff

                        LSU Multispecialty Clinic: Staff

 

            DIALYSIS UNIT:     Medical Director – Baton Rouge Davita HDU

                                                Medical Director – Crescent City Davita HDU

 

            INPATIENT SERVICE ACTIVITIES:

                        MCLNO: Attending

                        UNIVERSITY HOSPITAL: Attending

                        BAPTIST HOSPITAL: Attending

                        LINDY BOGGS MEDICAL CENTER: Attending

                        EARL K LONG, Baton Rouge: Attending

                        Baton Rouge General Hospital, Baton Rouge, LA: Attending

                        Ochner Medical Center Kenner, Kenner, LA: Attending

                        Touro Infirmary, New Orleans, LA: Attending

                        Meadowcrest HospitalAttending